Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: Lgals5 (lectin, galactose binding, soluble 5) Rattus norvegicus
Analyze
Symbol: Lgals5
Name: lectin, galactose binding, soluble 5
Description: Predicted to have integrin binding activity and lactose binding activity. Predicted to be involved in lymphatic endothelial cell migration and positive regulation of T cell apoptotic process. Predicted to localize to the cytoplasm. Orthologous to human LGALS9 (galectin 9); LGALS9B (galectin 9B); and LGALS9C (galectin 9C); INTERACTS WITH (RS)-amphetamine; 17alpha-ethynylestradiol; 2,4-dinitrotoluene.
Type: protein-coding
RefSeq Status: PROVISIONAL
Also known as: gal-5; galectin-5; Lectin galactose binding soluble 5 (Galectin-5); RL-18
Orthologs:
Homo sapiens (human) : LGALS16 (galectin 16)  HGNC
more info ...
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.01066,226,015 - 66,229,293 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.01065,415,954 - 65,419,232 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41065,075,525 - 65,078,686 (-)NCBIRGSC3.4rn4RGSC3.4
RGSC_v3.11065,089,147 - 65,092,309 (-)NCBI
Celera1062,829,699 - 62,832,860 (-)NCBICelera
Cytogenetic Map10q25NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
References - uncurated
RGD Disease Portals

Genomics

Comparative Map Data
QTLs in Region (Rnor_6.0)
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome
Promoters

Strain Variation

Strain Sequence Variants (Rnor 5.0)

Additional Information

External Database Links
Nomenclature History
RGD Curation Notes
 
More on Lgals5
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

RGD Object Information
RGD ID: 3004
Created: 2000-05-25
Species: Rattus norvegicus
Last Modified: 2019-04-23
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.